Xeris Pharmaceuticals | XERS - Bénéfice Avant Impôts

Prix De L'Action
5.85
Variation Quotidienne
-0.16 -2.66%
Mensuellement
2.09%
Annuel
40.63%
Q2 Prévisions
5.86




Bénéfice Avant Impôts Changement Date
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 134.73M 7.91M 2025-09
Sartorius EUR 85M 14.1M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06